The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Onyx Pharmaceuticals

  • ONXX
  • NASDAQ
  • Consumer Products
  • Latest 124.70
  • Currency US$
  • Change 0.0000
  • Percent Change 0.00 %
  • Volume 0
  • Mon Sep 30, 2013 04:00 PM EDT NASDAQ data delayed 15 minutes.
  • Open 0.0000
  • Previous Close 124.70
  • High 0.0000
  • Low 0.0000
  • Bidx0 0.0000
  • Askx0 0.0000
  • 52-week High07/08 136.87
  • 52-week Low06/24 79.11
  • Beta 1.34
  • Market Cap
  • EPS -3.05
  • P/E
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales n/a
  • Earnings n/a
  • Return on Equity n/a

Cash Flow

  • Cash Flow n/a
  • Cash n/a
  • Current Ratio n/a

12 months ended n/a.

Trailing 12 month results shown above.
All data is in dollars.

Balance Sheet

  • Assets n/a
  • Liabilities n/a
  • Liabilities-to-Equity Ratio n/a

Price Ratios

  • Price to Sales n/a
  • Price to Book n/a
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Feb 20 $-0.72 n/a n/a
Surprises Aug 8 -9.52% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Apr 20, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Related Securities
Symbol Type Latest % Chg

Officers

  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: n/a,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

No address found.

Ideas & Discussion

Live Discussion of ONXX on StockTwits